Company Layoffs & Restructurings, Week of Aug 3, 2026: 8-K Filings
In the week of Aug 3, 2026 to Aug 9, 2026, 6 companies disclosed a workforce reduction or restructuring plan in 6 SEC filings (8-K Item 2.05 or the company's own announcement), according to EquiReason's reading of the filings.
Source: SEC EDGAR filings · Aug 3, 2026 – Aug 9, 2026 · read by EquiReason
| Date | Company | Filing | What the filing reports |
|---|---|---|---|
| 2026-08-07 | GFF Griffon Corporation | 8-K · 8.01, 9.01 | Recast financials to reflect discontinued operations from AMES North America JV, AMES Australasia sale, and AMES UK liquidation. Company now one reportable segment. Strategic exit from non-core businesses. |
| 2026-08-07 | ATYR aTyr Pharma, Inc. | 8-K · 2.02, 9.01 | aTyr Pharma announces 60% workforce reduction, CFO and GC departures, to reduce annualized opex by ~$13M. Focuses on efzofitimod ILD program; cash runway into late 2028. |
| 2026-08-06 | NRDY Nerdy Inc. | 8-K · 2.05 | Nerdy Inc. committed to wind down its Varsity Tutors for Schools business line, with estimated exit-related costs of $2M-$4M, including severance, contract termination, and asset impairment charges. |
| 2026-08-05 | CHYM Chime Financial, Inc. | 8-K · 2.02, 2.05, 5.02, 9.01 | — |
| 2026-08-04 | NTNX Nutanix, Inc. | 8-K · 2.05 | Nutanix announced a 5% workforce reduction with estimated pre-tax charges of $33M-$43M, primarily severance costs, to streamline operations and reallocate resources to strategic priorities. |
| 2026-08-04 | BIO Bio-Rad Laboratories, Inc. | 8-K · 2.02, 2.05, 7.01, 9.01 | Bio-Rad initiates restructuring plan with $80-90M pre-tax charges, including layoffs and facility closures, to improve operating performance. |
Questions
- Which companies announced layoffs in the week of aug 3, 2026?
- Griffon Corporation (GFF), aTyr Pharma, Inc. (ATYR), Nerdy Inc. (NRDY), Chime Financial, Inc. (CHYM), Nutanix, Inc. (NTNX), Bio-Rad Laboratories, Inc. (BIO) — the full list, with dates and the filing behind each row, is above.
Earlier weeks
2026 W43 · 2026 W42 · 2026 W41 · 2026 W40 · 2026 W39 · 2026 W38 · 2026 W37 · 2026 W36 · 2026 W35 · 2026 W34 · 2026 W33 · 2026 W32 · Other lists: Guidance raised or cut · Insider buying · Executive and board changes · Mergers and acquisitions · Stock buybacks announced
How these figures are read: methodology · EquiReason.